UNSPSC 51422303: Betamethasone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9842X06Q6M, chemically known as 9-fluoro-11.beta.,17, 21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione but generally known as betamethasone, which bears US NIH Compound Identifier 3003.

Betamethasone comes in many forms, including base, acetate, acetate phosphate, acibutate, alcohol, benzoate, butyrate propionate, dihydrogen phosphate, dipropionate, disodium phosphate, phosphate, sodium, sodium phosphate, valerate, 17, 21-dipropionate, 17-acetate, 17 alpha-monopropionate, 17-benzoate, 17-dipropionate, 17-propionate, 17-propionate 21-methoxide, 17-valerate, 21-acetate, 21-disodium phosphate, 21-pentanoate, 21-phosphate, 21-phosphate disodium, and 21-valerate.

UNSPSC 51422303 Betamethasone is a Commodity code nominally identifying a specific corticosteroid pharmaceutical, but recent state and local solicitations tagged under this code show little alignment with betamethasone procurement itself. The Seminole County, Florida IFB (IFB60459723LAS, due Jul 26, 2026) seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives—opioid-reversal and harm-reduction supplies rather than betamethasone. The Texas Health and Human Services Commission RFI (HHS0017013, posted Apr 3, 2026) solicits vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program spanning negotiated net pricing models and outcomes-based agreements across multiple drug categories, with no specific betamethasone focus. The code shows limited recent activity directly purchasing the commodity it nominally describes; state and local buyers are instead using this classification for broader pharmaceutical procurement and pharmacy benefit management infrastructure.

Issuing bodies on recent opportunities include county health departments (Seminole County, Florida) and state HHS agencies (Texas Health and Human Services Commission). Geographic activity centers on Florida and Texas in the immediate recent record. The Seminole County IFB requires quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for shipping and all delivery costs included in pricing; the contract carries a two-year initial term with one-year renewal option and a three-month probationary period. The Texas RFI is exploratory, gathering market intelligence before formal RFP development; it does not establish budget, timeline, or award values at this stage. Neither solicitation specifies set-asides for disadvantaged enterprises. Given the mismatch between the code's nominal scope and the actual pharmaceutical and pharmacy-operations work being solicited, business development professionals should confirm with the issuing bodies whether betamethasone procurement exists in their current procurement plans or whether the code assignment reflects broader pharmaceutical-acquisition activity.